2 years ago

Upfront Diagnostics Secures £1.6M Seed Funding for Stroke Detection Technology

  • Upfront Diagnostics, a Cambridge, UK-based healthcare company focused on discovering novel biomarkers for medical diagnosis, has raised £1.6 million in seed funding

  • The investment was led by APEX Ventures' Medical Fund, with support from SBRI Healthcare and the Stroke Association

  • Upfront Diagnostics has developed a point-of-care rapid blood test to help paramedics and other community health professionals to identify stroke in the community

  • The test can detect a stroke caused by a large vessel occlusion (LVO) within 15 minutes, enabling patients to be fast-tracked for treatment at a specialized stroke center

  • The funding will be used to scale the technology, expand the team, and prepare for clinical approval.

      • ProblemHealthcare

      "Identifying a large artery stroke quickly and accurately to enable patients to be fast-tracked for treatment and increase chances of saving lives and reducing disability"

      Solution

      "Developing a point-of-care rapid blood test to detect a stroke caused by a large vessel occlusion (LVO) within 15 minutes, allowing patients to be fast-tracked for treatment to a specialized stroke centre"

      Covered on